Envoy Medical (NASDAQ:COCH – Get Free Report) is one of 51 publicly-traded companies in the “Surgical appliances & supplies” industry, but how does it weigh in compared to its competitors? We will compare Envoy Medical to related companies based on the strength of its earnings, valuation, analyst recommendations, risk, institutional ownership, profitability and dividends.
Earnings & Valuation
This table compares Envoy Medical and its competitors gross revenue, earnings per share and valuation.
Gross Revenue | Net Income | Price/Earnings Ratio | |
Envoy Medical | $225,000.00 | -$29.91 million | -0.95 |
Envoy Medical Competitors | $1.41 billion | $234.66 million | 19.80 |
Envoy Medical’s competitors have higher revenue and earnings than Envoy Medical. Envoy Medical is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
Volatility & Risk
Insider and Institutional Ownership
8.6% of Envoy Medical shares are held by institutional investors. Comparatively, 45.5% of shares of all “Surgical appliances & supplies” companies are held by institutional investors. 60.5% of Envoy Medical shares are held by insiders. Comparatively, 10.2% of shares of all “Surgical appliances & supplies” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Profitability
This table compares Envoy Medical and its competitors’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Envoy Medical | -7,607.55% | N/A | -262.28% |
Envoy Medical Competitors | -169.94% | -74.14% | -20.85% |
Analyst Recommendations
This is a breakdown of current recommendations for Envoy Medical and its competitors, as provided by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Envoy Medical | 0 | 0 | 2 | 0 | 3.00 |
Envoy Medical Competitors | 401 | 1407 | 2531 | 116 | 2.53 |
Envoy Medical currently has a consensus target price of $9.00, indicating a potential upside of 571.64%. As a group, “Surgical appliances & supplies” companies have a potential upside of 34.94%. Given Envoy Medical’s stronger consensus rating and higher probable upside, equities research analysts plainly believe Envoy Medical is more favorable than its competitors.
Summary
Envoy Medical competitors beat Envoy Medical on 7 of the 13 factors compared.
Envoy Medical Company Profile
Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.
Receive News & Ratings for Envoy Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envoy Medical and related companies with MarketBeat.com's FREE daily email newsletter.